[1] Spearman CW, Dusheiko GM, Hellard M, Sonderup M. Hepatitis C. Lancet 2019;394(10207):1451 − 66. http://dx.doi.org/10.1016/s0140-6736(19)32320-7CrossRef
[2] World Health Organization. Fact-sheet: Hepatitis C. https://www.who.int/news-room/fact-sheets/detail/hepatitis-c. [2020-06-18].https://www.who.int/news-room/fact-sheets/detail/hepatitis-c
[3] World Health Organization. Global hepatitis report, 2017. http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/. [2018-03-20].http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/
[4] Heffernan A, Cooke GS, Nayagam S, Thursz M, Hallett TB. Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model. Lancet 2019;393(10178):1319 − 29. http://dx.doi.org/10.1016/s0140-6736(18)32277-3CrossRef
[5] Carrat F, Fontaine H, Dorival C, Simony M, Diallo A, Hezode C, et al. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. Lancet 2019;393(10179):1453 − 64. http://dx.doi.org/10.1016/s0140-6736(18)32111-1CrossRef
[6] GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392(10159):1789 − 858. http://dx.doi.org/10.1016/S0140-6736(18)32279-7CrossRef
[7] World Health Organization. Egypt: 35 million people receive hepatitis C test. https://www.who.int/hepatitis/news-events/egypt-hepatitis-c-testing/en/. [2020-06-20].https://www.who.int/hepatitis/news-events/egypt-hepatitis-c-testing/en/
[8] Ryerson AB, Schillie S, Barker LK, Kupronis BA, Wester C. Vital signs: newly reported acute and chronic hepatitis C cases - United States, 2009-2018. MMWR Morb Mortal Wkly Rep 2020;69(14):399 − 404. http://dx.doi.org/10.15585/mmwr.mm6914a2CrossRef
[9] WHO Regional Office for Europe. Hepatitis C in the WHO European region. https://www.euro.who.int/__data/assets/pdf_file/0009/377253/Fact-Sheet-Hepatitis-C_2019_ENG.PDF. [2020-06-20].https://www.euro.who.int/__data/assets/pdf_file/0009/377253/Fact-Sheet-Hepatitis-C_2019_ENG.PDF
[10] Dyal HK, Aguilar M, Bhuket T, Liu B, Holt EW, Torres S, et al. Concurrent obesity, diabetes, and steatosis increase risk of advanced fibrosis among HCV patients: a systematic review. Dig Dis Sci 2015;60(9):2813 − 24. http://dx.doi.org/10.1007/s10620-015-3760-3CrossRef